Circulating antiovarian antibodies in premature ovarian failure

Marian D. Damewood, Howard A. Zacur, Gary J. Hoffman, John A. Rock

Research output: Contribution to journalArticle

Abstract

The presence of antiovarian antibodies in sera of women with premature ovarian failure was determined by an indirect fluorescent antibody assay using human ovarian tissue. Of 27 patients, 14 had positive ovarian fluorescence, compared with zero of 24 normal cycling controls (P <.001) and one of 22 postmenopausal controls (P <.01). In patients with autoimmune diseases, five of 17 demonstrated positive fluorescence compared with zero of 24 premenopausal controls (P <.01). Immunoperoxidase staining revealed antigen concentrated at the granulosa cells and oocyte in nine of the 14 ovarian failure cases. The finding that a significant proportion of patients with premature ovarian failure have circulating antiovarian antibodies confirms previous studies, but localization of peroxidase staining to granulosa cells and/or oocytes represents a new finding in this study. (C) 1986 The American College of Obstetricians and Gynecologists.

Original languageEnglish (US)
Pages (from-to)850-854
Number of pages5
JournalObstetrics and gynecology
Volume68
Issue number6
StatePublished - Dec 1986

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Circulating antiovarian antibodies in premature ovarian failure'. Together they form a unique fingerprint.

  • Cite this

    Damewood, M. D., Zacur, H. A., Hoffman, G. J., & Rock, J. A. (1986). Circulating antiovarian antibodies in premature ovarian failure. Obstetrics and gynecology, 68(6), 850-854.